Terns Pharmaceuticals Inc (TERN)
R&D Expense Growth
-5.11%
Quarterly · Period ending:
TERN R&D Expense Growth
Latest reported-5.11%period ending
Latest reported-5.11%period ending
TERN Quarterly R&D Growth (QoQ) (0.00% → -5.11%)
Latest values, visible window
High-resolution chart · PNG
TERN r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -5.1112% | |
| -2.1422% | |
| 8.7233% | |
| 3.9769% | |
| 18.6894% | |
| -17.3442% | |
| -1.2643% | |
| 6.4609% | |
| 17.7196% | |
| 4.8053% | |
| -17.0321% | |
| 60.03% | |
| -12.3592% | |
| 40.3948% | |
| 6.4651% | |
| -14.014% | |
| 32.2802% | |
| 19.9966% | |
| -31.7573% | |
| 12.4196% | |
| 43.7824% | |
| -28.9975% | |
| 5.0663% | |
| -4.1292% | |
| 0% |